Guide to bone health and disease in cystic fibrosis
- PMID: 15613415
- DOI: 10.1210/jc.2004-1629
Guide to bone health and disease in cystic fibrosis
Abstract
Cystic fibrosis (CF) is the most common genetic disease within the Caucasian population and leads to premature respiratory failure. Approximately 60,000 individuals are currently living with CF in North America and Europe, 40% of whom are adults. The life span of these patients has increased from approximately 2 to 32 yr of age over the last three decades. Bone disease has emerged as a common complication in long-term survivors of CF. Some studies have observed that 50-75% of adults have low bone density and increased rates of fractures. Prevention and treatment of CF-related bone disease must address the myriad risk factors (decreased absorption of fat-soluble vitamins due to pancreatic insufficiency, altered sex hormone production, chronic lung infection with increased levels of bone-active cytokines, physical inactivity, and glucocorticoid therapy) for poor bone health. This review is a condensed and updated summary of the Guide to Bone Health and Disease in Cystic Fibrosis: A Consensus Conference, a statement that evolved from a meeting convened by the Cystic Fibrosis Foundation in May 2002 to address the pathogenesis, diagnosis, and treatment of bone disease in CF. The goal of this conference was to develop practice guidelines for optimizing bone health in patients with CF.
Similar articles
-
'Old' bones in young bodies: the tale of cystic fibrosis.Curr Opin Endocrinol Diabetes Obes. 2009 Dec;16(6):407-14. doi: 10.1097/MED.0b013e3283329b16. Curr Opin Endocrinol Diabetes Obes. 2009. PMID: 19816169 Review.
-
Treatment of bone disease in cystic fibrosis.Curr Opin Pulm Med. 2004 Nov;10(6):524-30. doi: 10.1097/01.mcp.0000142923.00683.d2. Curr Opin Pulm Med. 2004. PMID: 15510061 Review.
-
Diabetes mellitus and bone disease in cystic fibrosis.Semin Respir Crit Care Med. 2009 Oct;30(5):514-30. doi: 10.1055/s-0029-1238910. Epub 2009 Sep 16. Semin Respir Crit Care Med. 2009. PMID: 19760539 Review.
-
Update on maintaining bone health in cystic fibrosis.Curr Opin Pulm Med. 2006 Nov;12(6):453-8. doi: 10.1097/01.mcp.0000245708.59138.a4. Curr Opin Pulm Med. 2006. PMID: 17053497 Review.
-
Management of osteoporosis in adults with cystic fibrosis.Drugs. 2004;64(2):133-47. doi: 10.2165/00003495-200464020-00002. Drugs. 2004. PMID: 14717616 Review.
Cited by
-
Bisphosphonates for osteoporosis in people with cystic fibrosis.Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD002010. doi: 10.1002/14651858.CD002010.pub5. Cochrane Database Syst Rev. 2023. PMID: 36625789 Free PMC article. Review.
-
Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease.J Bras Pneumol. 2019 Feb 28;45(1):e20170280. doi: 10.1590/1806-3713/e20170280. J Bras Pneumol. 2019. PMID: 30843951 Free PMC article.
-
Findings from a feasibility study of estradiol for hypogonadal women with cystic fibrosis-related bone disease.Pilot Feasibility Stud. 2021 Aug 19;7(1):160. doi: 10.1186/s40814-021-00897-x. Pilot Feasibility Stud. 2021. PMID: 34412687 Free PMC article.
-
Vitamin D supplementation for cystic fibrosis.Cochrane Database Syst Rev. 2014 May 14;2014(5):CD007298. doi: 10.1002/14651858.CD007298.pub4. Cochrane Database Syst Rev. 2014. PMID: 24823922 Free PMC article. Review.
-
Resurrection of vitamin D deficiency and rickets.J Clin Invest. 2006 Aug;116(8):2062-72. doi: 10.1172/JCI29449. J Clin Invest. 2006. PMID: 16886050 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical